Evidence map›Paper›PMID 28342222›Full record

ArticleProteins2017

The H3 loop of antibodies shows unique structural characteristics.

Cristian Regep, Guy Georges, Jiye Shi, Bojana Popovic, Charlotte M Deane

Abstract read
In one paragraph

Article in Proteins, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Antibody Affinity Maturation by Computational Design.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Large scale paired antibody language models.PLoS computational biology · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cristian RegepDepartment of Statistics, University of Oxford, Oxford, OX1 3LB, United Kingdom.ORCID 0000-0001-5786-0798
Guy GeorgesPharma Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Penzberg, 82377, Germany.
Jiye ShiUCB Celltech, Branch of UCB Pharma S.A., Slough, SL1 3WE, United Kingdom.
Bojana PopovicMedImmune Ltd., Department of Antibody Discovery and Protein Engineering, Cambridge, CB21 6GH, United Kingdom.
Charlotte M DeaneDepartment of Statistics, University of Oxford, Oxford, OX1 3LB, United Kingdom.ORCID 0000-0003-1388-2252

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The H3 loop in the Complementarity Determining Region of antibodies plays a key role in their ability to bind the diverse space of potential antigens. It is also exceptionally difficult to model computationally causing a significant hurdle for in silico development of antibody biotherapeutics. In this article, we show that most H3s have unique structural characteristics which may explain why they are so challenging to model. We found that over 75% of H3 loops do not have a sub-Angstrom structural neighbor in the non-antibody world. Also, in a comparison with a nonredundant set of all protein fragments over 30% of H3 loops have a unique structure, with the average for all of other loops being less than 3%. We further observed that this structural difference can be seen at the level of four residue fragments where H3 loops present numerous novel conformations, and also at the level of individual residues with Tyrosine and Glycine often found in energetically unfavorable conformations. Proteins 2017; 85:1311-1318. © 2017 Wiley Periodicals, Inc.

Indexed as

AlgorithmsAntibodiesAntigensBinding SitesComplementarity Determining RegionsGlycineHumansImmunoglobulin Heavy ChainsProtein BindingProtein FoldingProtein Structure, SecondarySoftwareTemperatureThermodynamicsTyrosineAntibodiesAntigensComplementarity Determining RegionsGlycineImmunoglobulin Heavy ChainsTyrosineantibodiesCDR H3Glycineloop modelingprotein loopstructural diversityTyrosine

Identifiers

PMID28342222
PMCPMC5535007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.